Lewes, DE -- (SBWIRE) -- 07/18/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Alexandria Real Estate Equities Inc (OTCMKTS:AREEP), Marathon Patent Group Inc (OTCBB:MARA), Talon Therapeutics Inc (OTCBB:TLON), Great Florida Bank (OTCMKTS:GFLB)
Alexandria Real Estate Equities Inc (OTCMKTS:AREEP) declined -0.42%, trading on 56,547 shares to end the trade at $25.84. If we look at its trading history of past 52 weeks, the share price suffered low of $25.00 and was moved to maximum level of $29.00.The stock changed hands in a range of $25.60 to $26.00, bringing its market capitalization at about $4.93 billion. Alexandria Real Estate Equities, Inc., a real estate investment trust (REIT), engages in the ownership, operation, management, development, acquisition, and redevelopment of properties for the life sciences industry.
Will AREEP Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Marathon Patent Group Inc (OTCBB:MARA) added 12.50% to complete the trading session at $0.450 with a total volume of 3.34 million shares. The stock, on average, trades on a volume of 241,169 shares. In the past 52 weeks, the share price has not declined below $0.20 and above $1.01.It floated in a range of $0.40 to $0.47 .Its market capitalization now moved to about $21.02 million. Marathon Patent Group, Inc. engages in the acquisition, development, and monetization of intellectual property through the prosecution and licensing of its patent portfolio. The company provides advice and services that enable its clients to realize financial and strategic return on their intellectual property rights.
What was the Moving Force behind MARA On Bullish Run? Read This Research Report
Talon Therapeutics Inc (OTCBB:TLON) recorded a fall of -57.84% and was in a range of $0.12-$-0.45 before closing at $0.156. The share price hit its 52-week low of $0.12 and $1.83 was the best price. The stock completed the day with a total volume of 5.75 million shares versus an average volume of 30,764 shares. Talon Therapeutics, Inc., a biopharmaceutical company, develops and commercializes new and differentiated cancer therapies. Its lead product includes Marqibo (vincristine sulfate liposome injection), which is a novel sphingomyelin/cholesterol liposome encapsulated formulation of vincristine for acute lymphoblastic leukemia and non-Hodgkins lymphoma.
Is it the Right to Grab TLON after the Recent Slump? Get Free Trend Analysis Here
Great Florida Bank (OTCMKTS:GFLB) added 812.50% yesterday, bringing its market capitalization around $38.29 million. The total number of shares changed hands during the session was 412,173 shares as compared to average trading volume of 1,896 shares. The share price after opening at $2.95 made a high of $3.00 and hovered above $2.75 to end the day at $2.92. Great Florida Bank provides various consumer and commercial banking products and services to individuals, businesses, and industries in southeast Florida. It offers interest-bearing and noninterest-bearing demand deposit accounts, money market deposit accounts, NOW accounts, time deposits, credit cards, cash management services, direct deposits, notary services, night depository services, cashiers checks, domestic collections, bank drafts, automated teller services, automated teller machine cards, and mobile and online banking services.
For How Long GFLB will fight for Profitability? Read This Trend Analysis report
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/